An attempt at administering a transdermal formulation of bisoprolol in patients with acute cardiac symptoms
Bisono ® is the world's first transdermal formulation of a bisoprolol, which is approved for the treatment of hypertension in Japan. We aimed to investigate the usefulness of this formulation in patients who were admitted to our hospital with cardiac symptoms suggestive of acute coronary syndrome or an ac ute exacerbation of heart failure.
Source: The American Journal of Emergency Medicine - Category: Emergency Medicine Authors: Ayumu Nozaki, Tomoko Kobayashi, Kazumasa Naruhashi, Hiroshi Okugawa, Nozomu Horiuchi, Hirokazu Nakanishi, Yuka Kobayashi, Shigeru Nakamura Source Type: research
More News: Bisoprolol | Cardiology | Emergency Medicine | Heart | Heart Failure | Hospitals | Hypertension | Japan Health